Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1638
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18290257 | PRODUCTION OF ENGINEERED T CELLS FROM STEM CELLS | Non-Final OA | The Regents of the University of California |
| 17930810 | ADAPTATION OF PLATFORM HOSTS TO IGF- MEDIA | Final Rejection | Amgen Inc. |
| 18569642 | COMPOSITIONS COMPRISING SPHERICAL PARTICLES AND USES OF SAME | Non-Final OA | Technion Research & Development Foundation Limited |
| 18137267 | DEFINED MATRIX FOR THE DIFFERENTIATION OF ISLETS | Final Rejection | Washington University |
| 18318305 | TREATING OF NEUROLOGICAL DISORDERS USING EXTRACELLULAR VESICLES RELEASED BY HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED NEURAL STEM CELLS | Non-Final OA | THE TEXAS A&M UNIVERSITY SYSTEM |
| 18550548 | CONTROL OF MULTI-GENE EXPRESSION USING SYNTHETIC PROMOTERS | Final Rejection | ASTRAZENECA AB |
| 18332380 | GENERATION OF NEXT GENERATION RECOMBINANT AAV GENE THERAPY VECTORS THAT ADOPT 3D CONFORMATION | Non-Final OA | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 18510652 | COMPOSITION AND METHOD FOR THREE-DIMENSIONAL HISTOLOGICAL STAINING | Non-Final OA | JelloX Biotech Inc. |
| 18551038 | PHARMACEUTICAL COMPOSITIONS CONTAINING ADENO-ASSOCIATED VIRAL VECTOR | Non-Final OA | Pfizer Inc. |
| 18311464 | PROTECTION FROM OVARIAN FAILURE BY LOW DOSE INTERLEUKIN-2 ADMINISTRATION | Non-Final OA | CREATIVE MEDICAL TECHNOLOGIES, INC. |
| 18721342 | PRODUCTION OF GENE THERAPY VECTOR IN ENGINEERED BACTERIA | Non-Final OA | ALDEVRON, LLC |
| 18719518 | METHOD FOR PREPARING HIGHLY DIFFERENTIATED KIDNEY ORGANOIDS | Non-Final OA | RGENORGANO BIOTECHNOLOGY CO., LTD. |
| 18273631 | GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC FCRN | Non-Final OA | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
| 18403061 | ORGAN PERFUSION AND PRESERVATION SYSTEM AND METHOD | Non-Final OA | ASSISTNCE PUBLIQUE- HOPTAUX DE PARIS |
| 18401238 | OFF-THE-SHELF HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS AND PREPARATION METHOD AND USE THEREOF | Non-Final OA | WUHAN OPTICS VALLEY ZHONGYUAN PHARMACEUTICAL CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy